-
Oral Session III A
Mariana FiadeiroDone
-
Flash Session II (A)
Melissa MarianaDone
-
Flash Session II (C)
Carolina RibeiroDone
-
Lunch Break
Done
-
Oral Session III B
Ana R. CostaDone
-
Plenary Session III
Giovanni Viegi, M.D.; Ph.D.Done
-
Oral Session II A
Rita CarapitoDone
-
Flash Session I (B)
Clara B. MartinsDone
-
Plenary Session IV
Professor Jens PahnkeDone
-
Flash Session III (D)
Joana FerreiraDone
Enterprise Plenary Session III
15/02/2023, 09:40
-
15/02/2023, 10:40
(UTC)
(1 hour)
GenIbet Biopharmaceuticals is a company whose mission is to manufacture safe and reliable breakthrough products to support worldwide customers on building the therapies of the future. With a team of more than 50 highly qualified professionals, GenIbet supports its customers on the development and manufacturing of unique novel modalities covering a wide range of technologies.
Sofia Venceslau obtained her Ph.D. degree from the NOVA University of Lisbon, Institute of Chemical and Biological Technology (Oeiras, Portugal) in 2011 and is currently a Project Manager in GenIbet Biopharmaceuticals and will be the third confirmed enterprise speaker for the HSR Congress 2023 on February 15th, 2023.
